Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PACS (PACS) Other Non-Current Liabilities: 2023-2025

Historic Other Non-Current Liabilities for PACS (PACS) over the last 3 years, with Q3 2025 value amounting to $289.1 million.

  • PACS's Other Non-Current Liabilities rose 2315.27% to $289.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $289.1 million, marking a year-over-year increase of 2315.27%. This contributed to the annual value of $216.5 million for FY2024, which is 3286.25% up from last year.
  • PACS's Other Non-Current Liabilities amounted to $289.1 million in Q3 2025, which was up 2315.27% from $276.4 million recorded in Q2 2025.
  • Over the past 5 years, PACS's Other Non-Current Liabilities peaked at $289.1 million during Q3 2025, and registered a low of $154.9 million during Q1 2024.
  • In the last 3 years, PACS's Other Non-Current Liabilities had a median value of $216.5 million in 2024 and averaged $217.3 million.
  • In the last 5 years, PACS's Other Non-Current Liabilities tumbled by 496.02% in 2024 and then surged by 5651.42% in 2025.
  • PACS's Other Non-Current Liabilities (Quarter) stood at $163.0 million in 2023, then skyrocketed by 32.86% to $216.5 million in 2024, then soared by 33.5% to $289.1 million in 2025.
  • Its Other Non-Current Liabilities was $289.1 million in Q3 2025, compared to $276.4 million in Q2 2025 and $242.4 million in Q1 2025.